Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Vitalipid N Adult
Active Ingredients:	dl-Alpha tocopherol 0.91mg/mL Ergocalciferol 0.5mcg/mL Phytomenadione 15mcg/mL Retinol palmitate 194.1mcg/mL
Dosage Form:	Emulsion for injection
New Zealand Sponsor:	Fresenius Kabi New Zealand Limited
Manufacturer:	Fresenius Kabi AB, Uppsala, Sweden

*Product:*	Vitalipid N Infant
Active Ingredients:	dl-Alpha tocopherol 0.64mg/mL Ergocalciferol 1mcg/mL Phytomenadione 20mcg/mL Retinol palmitate 135.3mcg/mL
Dosage Form:	Emulsion for injection
New Zealand Sponsor:	Fresenius Kabi New Zealand Limited
Manufacturer:	Fresenius Kabi AB, Uppsala, Sweden

Dated this 8th day of August 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule